Financial News
Curevac N.V. (NQ: CVAC )
3.310
+0.120
(+3.76%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Curevac N.V.
![](https://cdn.benzinga.com/files/images/story/2022/08/26/moderna_covid-19_vaccine_2021_g.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_15608.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/18/covid-19_corona-5174671_1920__image_by_gerd_altmann_from_pixabay_.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/11/aapharma_27.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_4039.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2022/07/26/covid-19-vaccine-image_by_x3_from_pixabay.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2020/12/Stock-pfizervaccine-02-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2020/12/Stock-pfizervaccine-02-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/07/05/aapharma_7.png?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
From CureVac
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
CureVac Announces Voting Results of General Meeting
June 22, 2022
From CureVac
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
From CureVac
Via AccessWire
![](https://investorplace.com/wp-content/uploads/2019/11/bill-gates.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/05/25/lab-5740505_1920.jpg?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
Curevac Announces Financial Results For The First Quarter Of 2022 And Provides Business Update
May 25, 2022
From CureVac
Via AccessWire
Exposures
COVID-19
![](https://cdn.benzinga.com/files/images/story/2022/04/28/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2021 and Provides Business Update
April 28, 2022
From CureVac
Via AccessWire
Exposures
COVID-19
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_3789.jpeg?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
![](https://cdn.benzinga.com/files/images/story/2022/04/21/lab-5740505_1920.jpg?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
From CureVac
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV
March 30, 2022
From CureVac
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/24271.png?v=0)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.